NYSE: EWEdwards Lifesciences

    Edwards Lifesciences: results and news

    Every Edwards Lifesciences filing with the US SEC that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · Health Care · Latest 5 Nov 2026

    Stainless steel surgical clamps and forceps laid out on a green surgical drape

    NYSE: EWEdwards Lifesciences

    Edwards Lifesciences Q3 2026 Results: Net Income $308 Million on Revenue of $1.72 Billion

    Edwards Lifesciences (NYSE: EW) reported GAAP revenue of $1.72 billion and GAAP net income of $307.5 million attributable to the company for the third quarter of 2026, it said on 4 Nov 2026. Diluted EPS was $0.53 on a GAAP basis. Adjusted EPS, a company-defined measure that excludes items such as litigation expenses and an impairment charge, was $0.80.

    • US stocks
    • Earnings

    Blacklitt Research4 min read